Welcome to our dedicated page for Ametek news (Ticker: AME), a resource for investors and traders seeking the latest updates and insights on Ametek stock.
AMETEK, Inc. (NYSE: AME) is a leading global provider of industrial technology solutions, with annual sales of over $6 billion. The company operates through two primary segments: the Electronic Instruments Group (EIG) and the Electromechanical Group (EMG). EIG designs and manufactures advanced instruments for the process, aerospace, power, and industrial markets. EMG focuses on highly engineered automation solutions, thermal management systems, specialty metals, and electrical interconnects.
With a workforce of approximately 15,000 employees, AMETEK has a strong presence worldwide, operating over 120 manufacturing locations and maintaining 100 sales and service locations in more than 30 countries. The company is committed to four key growth strategies: Operational Excellence, Strategic Acquisitions & Alliances, Global & Market Expansion, and New Product Development. Through these strategies, AMETEK aims to double its size and profitability within the next five years.
Recent achievements include the acquisition of Paragon Medical for approximately $1.9 billion, further enhancing AMETEK's capabilities in the medical technology sector. The company also declared a regular quarterly dividend of $0.28 per share, reflecting its strong financial performance and commitment to delivering shareholder value.
Founded in 1930 and listed on the NYSE for over 90 years, AMETEK is a component of the S&P 500. The company's disciplined focus on cash generation and capital deployment supports its long-term objective of achieving double-digit percentage growth in earnings per share and superior returns on total capital. For more information, visit www.ametek.com.
AMETEK, Inc. (NYSE: AME) has announced an 11% increase in its quarterly cash dividend to $0.20 per share, up from $0.18. This dividend is payable on March 31, 2021, to shareholders of record as of March 15, 2021, raising the annual rate to $0.80 per share. The company's strong cash flow allows it to invest in growth while rewarding investors. AMETEK reported over $4.5 billion in sales in 2020 and focuses on operational excellence, new product development, and strategic acquisitions to achieve double-digit earnings growth.
AMETEK announced the appointment of Karleen Oberton to its Board of Directors, effective February 11, 2021. Oberton currently serves as CFO of Hologic and has over 30 years of experience in public accounting, biotechnology, and medical device manufacturing. Her expertise in finance and executive leadership is expected to enhance AMETEK's board dynamics. The company reported 2020 sales exceeding $4.5 billion and aims for double-digit growth in earnings per share over the business cycle.
AMETEK reported Q4 2020 sales of $1.20 billion, an 8% decline from Q4 2019. Operating income rose to $298.1 million, yielding a record margin of 24.9%. GAAP earnings per share were $0.95, while adjusted earnings stood at $1.08. Cash flow surged, with operating cash flow up 13% to $386 million and free cash flow up 16% to $349 million. Looking ahead, AMETEK forecasts mid-single-digit sales growth for 2021, with adjusted earnings per diluted share expected between $4.18 and $4.30. Q1 2021 sales are projected to decline low to mid-single digits.
AMETEK, Inc. (NYSE: AME) will release its fourth quarter 2020 earnings on February 4, 2021, before market opens. The investor conference call will follow at 8:30 AM ET, accessible via the 'Events & Presentations' link on www.ametek.com. AMETEK, a leader in electronic instruments and electromechanical devices, reported approximately $5.0 billion in sales for 2019. The company aims for double-digit earnings growth and superior capital returns.
The Board of Directors of AMETEK declared a quarterly dividend of $0.18 per share for Q4, payable on December 24, 2020 to shareholders of record by December 7, 2020. In 2019, AMETEK reported sales of approximately $5.0 billion. The company employs a Growth Model emphasizing Operational Excellence, New Product Development, Global Expansion, and Strategic Acquisitions, aiming for double-digit earnings per share growth and superior capital returns.
AMETEK, Inc. reported Q3 2020 sales of $1.13 billion, a 12% decrease from Q3 2019. Operating income rose to $270.7 million, with operating margins reaching a record 24.0%. GAAP earnings per diluted share were $0.88, while adjusted earnings fell 5% to $1.01, reflecting ongoing challenges from the COVID-19 pandemic. The Electronic Instruments Group saw an 8% drop in sales, while the Electromechanical Group's sales declined by 18%. AMETEK reinstated guidance expecting Q4 sales to be down high single digits year-over-year and adjusted earnings between $1.00 and $1.04.
AMETEK, Inc. (NYSE: AME) is set to release its third quarter 2020 earnings on October 29, 2020, before the market opens. An investor conference call will follow at 8:30 AM ET, accessible via the company's website. The company, a leading manufacturer with approximately $5.0 billion in sales for 2019, aims for double-digit percentage growth in earnings per share. AMETEK is part of the S&P 500 index, focusing on operational excellence, new product development, global expansion, and strategic acquisitions to enhance cash generation and capital deployment.
The Board of Directors of AMETEK, Inc. (NYSE: AME) has declared a quarterly dividend of $0.18 per share for Q3, payable on September 30, 2020. Shareholders on record by September 14, 2020 will receive this dividend. AMETEK, a top manufacturer of electronic instruments and electromechanical devices, achieved sales of approximately $5.0 billion in 2019. The company aims for double-digit growth in earnings per share over the business cycle while maintaining a strong focus on cash generation and capital deployment.
AMETEK reported Q2 2020 financial results with sales of $1.01 billion, a decline of 22% compared to Q2 2019. Operating income was $227 million with margins at 22.4%. GAAP earnings per diluted share were $0.72, while adjusted earnings were $0.84, factoring in intangible amortization. Cash flow from operations rose 28% to $315 million. The Electronic Instruments Group (EIG) saw sales drop to $647.9 million (down 21%), while the Electromechanical Group (EMG) had sales at $364 million (down 22%). No forward guidance was provided due to COVID-19 uncertainties.
AMETEK, Inc. (NYSE: AME) will release its second quarter 2020 earnings report before the market opens on August 4, 2020. The company will host a webcast of the investor conference call on the same day, starting at 8:30 AM ET, accessible via their website. AMETEK, a global leader in electronic instruments and electromechanical devices, reported sales of approximately $5.0 billion in 2019. The firm emphasizes a growth strategy focusing on operational excellence, innovation, market expansion, and strategic acquisitions, aiming for double-digit percentage growth in earnings per share.
FAQ
What is the current stock price of Ametek (AME)?
What is the market cap of Ametek (AME)?
What does AMETEK, Inc. do?
What are the key business segments of AMETEK?
How many employees does AMETEK have?
What are AMETEK's growth strategies?
What recent acquisitions has AMETEK made?
What is AMETEK's annual sales figure?
When was AMETEK founded?
Is AMETEK listed on any stock exchange?
What is AMETEK's dividend policy?
Where can I find more information about AMETEK?
